EDGAR Filing Documents for 0001104659-23-063162

Form 8-K - Current report:

SEC Accession No. 0001104659-23-063162

Filing Date

2023-05-22

Accepted

2023-05-22 16:25:14

Documents

Period of Report

2023-05-21

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm2316415d1_8k.htm iXBRL	8-K	65377
2	EXHIBIT 2.1	tm2316415d1_ex2-1.htm	EX-2.1	633466
3	EXHIBIT 10.1	tm2316415d1_ex10-1.htm	EX-10.1	1629301
4	EXHIBIT 99.1	tm2316415d1_ex99-1.htm	EX-99.1	147236
5	EXHIBIT 99.2	tm2316415d1_ex99-2.htm	EX-99.2	44656
9	GRAPHIC	tm23164151ex99-2img001.jpg	GRAPHIC	28810
	Complete submission text file	0001104659-23-063162.txt		3240691

Data Files

Seq	Description	Document	Type	Size
6	XBRL TAXONOMY EXTENSION SCHEMA	irwd-20230521.xsd	EX-101.SCH	3051
7	XBRL TAXONOMY EXTENSION LABEL LINKBASE	irwd-20230521_lab.xml	EX-101.LAB	34476
8	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	irwd-20230521_pre.xml	EX-101.PRE	22607
11	EXTRACTED XBRL INSTANCE DOCUMENT	tm2316415d1_8k_htm.xml	XML	3621

Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110

Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722

IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)